BCDA - התחייבויות לטווח ארוך להון BioCardia Inc

This chart of BioCardia, Inc. (BCDA) share prices with the 0.00 metric refers to a business operated by experts in cardiac cell delivery. BioCardia, Inc. (BCDA) relies on a scientific approach and patient care, yet faces funding shortages and the risk of clinical trial failure. Meanwhile, operating in the US guarantees intellectual property protection and minimal external political influence.

Investors assess business resilience through the balance of equity and debt resources. This ratio measures the proportion of long-term loans relative to equity, determining the issuer's degree of financial autonomy. For BioCardia, Inc. (BCDA), which focuses on clinical trials without a merger strategy, this parameter is critical when financing research. Analyzing the ratio of liabilities exceeding one year to equity allows for the timely detection of credit overload. The trend of this indicator on the chart signals risks of shareholder value dilution.